{"abstract": "Shares in Regado Biopharmaceuticals, a drug maker and the only company to stage its market debut on Thursday, had risen more than 20 percent before Nasdaq halted trading in all its listed stocks.", "web_url": "https://dealbook.nytimes.com/2013/08/22/nasdaqs-halt-pauses-a-good-day-for-a-newly-public-company/", "snippet": "Shares in Regado Biopharmaceuticals, a drug maker and the only company to stage its market debut on Thursday, had risen more than 20 percent before Nasdaq halted trading in all its listed stocks.", "lead_paragraph": "Updated, 6:35 p.m. | Before the Nasdaq stock market halted trades just after noon on Thursday, Regado Biosciences had been having a pretty good day.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Nasdaq\u2019s Halt Briefly Pauses a Good Day for a Newly Public Company", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Initial Public Offerings", "rank": 2, "major": "N"}, {"name": "subject", "value": "Nasdaq Composite Index", "rank": 3, "major": "N"}, {"name": "organizations", "value": "NASDAQ OMX Group Inc", "rank": 4, "major": "N"}], "pub_date": "2013-08-22T18:42:48+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/eb986228-4498-5b6c-b25b-ea877143011f", "word_count": 218, "uri": "nyt://article/eb986228-4498-5b6c-b25b-ea877143011f"}